Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 9839631
[patent_doc_number] => 20150031713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'ARYL METHYL BENZOQUINAZOLINONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/509580
[patent_app_country] => US
[patent_app_date] => 2014-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20980
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14509580
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/509580 | ARYL METHYL BENZOQUINAZOLINONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | Oct 7, 2014 | Abandoned |
Array
(
[id] => 10187547
[patent_doc_number] => 09216958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-22
[patent_title] => '2,6-dihalo-5-alkoxy-4-substituted-pyrimidines, pyrimidine-carbaldehydes, and methods of formation and use'
[patent_app_type] => utility
[patent_app_number] => 14/505380
[patent_app_country] => US
[patent_app_date] => 2014-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8266
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14505380
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/505380 | 2,6-dihalo-5-alkoxy-4-substituted-pyrimidines, pyrimidine-carbaldehydes, and methods of formation and use | Oct 1, 2014 | Issued |
Array
(
[id] => 11250342
[patent_doc_number] => 09475832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-25
[patent_title] => 'Phosphonates with reduced toxicity for treatment of viral infections'
[patent_app_type] => utility
[patent_app_number] => 14/499865
[patent_app_country] => US
[patent_app_date] => 2014-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27876
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14499865
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/499865 | Phosphonates with reduced toxicity for treatment of viral infections | Sep 28, 2014 | Issued |
Array
(
[id] => 11010940
[patent_doc_number] => 20160207894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'Synthesis of Diacids, Dialdehydes, or Diamines from THF-Diols'
[patent_app_type] => utility
[patent_app_number] => 14/914284
[patent_app_country] => US
[patent_app_date] => 2014-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5718
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914284
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/914284 | Synthesis of Diacids, Dialdehydes, or Diamines from THF-Diols | Sep 24, 2014 | Abandoned |
Array
(
[id] => 10627577
[patent_doc_number] => 09345717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Method for improving drug treatments in mammals'
[patent_app_type] => utility
[patent_app_number] => 14/497022
[patent_app_country] => US
[patent_app_date] => 2014-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3745
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14497022
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/497022 | Method for improving drug treatments in mammals | Sep 24, 2014 | Issued |
Array
(
[id] => 11857960
[patent_doc_number] => 09737628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'High-coverage, low oder malodor counteractant compounds and methods of use'
[patent_app_type] => utility
[patent_app_number] => 14/496680
[patent_app_country] => US
[patent_app_date] => 2014-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8660
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14496680
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/496680 | High-coverage, low oder malodor counteractant compounds and methods of use | Sep 24, 2014 | Issued |
Array
(
[id] => 11067609
[patent_doc_number] => 20160264573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'PROCESS FOR PRODUCING DIAZABICYCLOOCTANE DERIVATIVE AND INTERMEDIATE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/023976
[patent_app_country] => US
[patent_app_date] => 2014-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48135
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023976
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/023976 | Process for producing diazabicyclooctane derivative and intermediate thereof | Sep 23, 2014 | Issued |
Array
(
[id] => 11971108
[patent_doc_number] => 20170275262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'CYCLOPROPANE DERIVATIVES IN FLAVOR AND FRAGRANCE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/509026
[patent_app_country] => US
[patent_app_date] => 2014-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5003
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15509026
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/509026 | CYCLOPROPANE DERIVATIVES IN FLAVOR AND FRAGRANCE COMPOSITIONS | Sep 18, 2014 | Abandoned |
Array
(
[id] => 11785140
[patent_doc_number] => 09394491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-19
[patent_title] => 'Process for in-situ electrochemical oxidative generation and conversion of organosulfur compounds'
[patent_app_type] => utility
[patent_app_number] => 14/487726
[patent_app_country] => US
[patent_app_date] => 2014-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4059
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14487726
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/487726 | Process for in-situ electrochemical oxidative generation and conversion of organosulfur compounds | Sep 15, 2014 | Issued |
Array
(
[id] => 9793549
[patent_doc_number] => 20150005491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'CRYSTALLINE (6R,7R)-7--3- [(R)-1\'-TERT-BUTOXYCARBONYL-2-OXO-[1,3\']BIPYRROLIDINYL-(3E)-YLIDENEMETHYL]-8-OXO-5-THIA-1-AZA-BICYCLO[4.2.0] OCT-2-ENE-2-CARBOXYLIC ACID BENZHYDRYL ESTER; ITS MANUFACTURE AND USE'
[patent_app_type] => utility
[patent_app_number] => 14/486205
[patent_app_country] => US
[patent_app_date] => 2014-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23173
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486205
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/486205 | Crystalline (6R,7R)-7-{2-(5-amino-[1,2,4] thiadiazol-3-yl)-2-[(Z)-trityloxyimino]-acetylamino}-3-[(R)-1′-tert-butoxycarbonyl-2-oxo-[1,3′]bipyrrolidinyl-(3E)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use | Sep 14, 2014 | Issued |
Array
(
[id] => 10590876
[patent_doc_number] => 09312498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Organic compound, light-emitting element, display module, lighting module, light-emitting device, display device, electronic appliance, and lighting device'
[patent_app_type] => utility
[patent_app_number] => 14/483743
[patent_app_country] => US
[patent_app_date] => 2014-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 64
[patent_no_of_words] => 27944
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14483743
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/483743 | Organic compound, light-emitting element, display module, lighting module, light-emitting device, display device, electronic appliance, and lighting device | Sep 10, 2014 | Issued |
Array
(
[id] => 10298793
[patent_doc_number] => 20150183792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 14/483898
[patent_app_country] => US
[patent_app_date] => 2014-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 31311
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14483898
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/483898 | Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use | Sep 10, 2014 | Issued |
Array
(
[id] => 10056249
[patent_doc_number] => 09095588
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Process for preparing 1-[2-(2,4-dimethylphenysulfanyl)-pheny]piperazine or pharmaceutically acceptable salt thereof'
[patent_app_type] => utility
[patent_app_number] => 14/472896
[patent_app_country] => US
[patent_app_date] => 2014-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 24
[patent_no_of_words] => 18352
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14472896
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/472896 | Process for preparing 1-[2-(2,4-dimethylphenysulfanyl)-pheny]piperazine or pharmaceutically acceptable salt thereof | Aug 28, 2014 | Issued |
Array
(
[id] => 11010944
[patent_doc_number] => 20160207898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'PROCESS FOR PURIFYING AN ACID COMPOSITION COMPRISING 2-FORMYL-FURAN-5-CARBOXYLIC ACID AND 2,5-FURANDICARBOXYLIC ACID'
[patent_app_type] => utility
[patent_app_number] => 14/914972
[patent_app_country] => US
[patent_app_date] => 2014-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7127
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14914972
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/914972 | Process for purifying an acid composition comprising 2-formyl-furan-5-carboxylic acid and 2,5-furandicarboxylic acid | Aug 28, 2014 | Issued |
Array
(
[id] => 10534798
[patent_doc_number] => 09260418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-16
[patent_title] => 'Pyranyl aryl methyl benzoquinolinone M1 receptor positive allosteric modulators'
[patent_app_type] => utility
[patent_app_number] => 14/470080
[patent_app_country] => US
[patent_app_date] => 2014-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32158
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14470080
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/470080 | Pyranyl aryl methyl benzoquinolinone M1 receptor positive allosteric modulators | Aug 26, 2014 | Issued |
Array
(
[id] => 11262124
[patent_doc_number] => 09486405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-08
[patent_title] => 'Methods for the treatment of pediatric otic disorders'
[patent_app_type] => utility
[patent_app_number] => 14/469408
[patent_app_country] => US
[patent_app_date] => 2014-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 17
[patent_no_of_words] => 43480
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14469408
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/469408 | Methods for the treatment of pediatric otic disorders | Aug 25, 2014 | Issued |
Array
(
[id] => 9865406
[patent_doc_number] => 20150045425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'PELTATIN AND METABOLIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/465807
[patent_app_country] => US
[patent_app_date] => 2014-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4437
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14465807
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/465807 | PELTATIN AND METABOLIC DISORDERS | Aug 20, 2014 | Abandoned |
Array
(
[id] => 9902143
[patent_doc_number] => 20150057344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'PELTATIN FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/465801
[patent_app_country] => US
[patent_app_date] => 2014-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5227
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14465801
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/465801 | PELTATIN FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISORDERS | Aug 20, 2014 | Abandoned |
Array
(
[id] => 10954624
[patent_doc_number] => 20140357646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'POLYMORPHS'
[patent_app_type] => utility
[patent_app_number] => 14/462654
[patent_app_country] => US
[patent_app_date] => 2014-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3190
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14462654
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/462654 | Polymorphs | Aug 18, 2014 | Issued |
Array
(
[id] => 10708159
[patent_doc_number] => 20160054306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'The cause and possible treatment of thyroid anti-body disease'
[patent_app_type] => utility
[patent_app_number] => 14/463194
[patent_app_country] => US
[patent_app_date] => 2014-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 801
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14463194
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/463194 | The cause and possible treatment of thyroid anti-body disease | Aug 18, 2014 | Abandoned |